Mutations of residues 249 and 256 in VP2 are involved in the replication and virulence of infectious Bursal disease virus

PLoS One. 2013 Jul 26;8(7):e70982. doi: 10.1371/journal.pone.0070982. Print 2013.

Abstract

Infectious bursal disease virus (IBDV) is a pathogen of worldwide significance to the poultry industry. Although the PDE and PFG domains of the capsid protein VP2 contribute significantly to virulence and fitness, the detailed molecular basis for the pathogenicity of IBDV is still not fully understood. Because residues 253 and 284 of VP2 are not the sole determinants of virulence, we hypothesized that other residues involved in virulence and fitness might exist in the PDE and PFG domains of VP2. To test this, five amino acid changes selected by sequence comparison of the PDE and PFG domains of VP2 were introduced individually using a reverse genetics system into the virulent strain (rGx-F9VP2). Then reverse mutations of the selected residues 249 and 256 were introduced individually into the attenuated strain (rGt). Seven modified viruses were generated and evaluated in vitro (CEF cells) and in vivo (SPF chicken). For residue 249, Q249R could elevate in vitro and reduce in vivo the replication of rGx-F9VP2 while R249Q could reduce in vitro and elevate in vivo the replication of rGt; meanwhile Q249R reduced the virulence of rGx-F9VP2 while R249Q increased the virulence of rGt, which indicated that residue 249 significantly contributed to the replication and virulence of IBDV. For residue 256, I256V could elevate in vitro and reduce in vivo the replication of rGx-F9VP2 while V256I could reduce in vitro but didn't change in vivo the replication of rGt; although V256I didn't increase the virulence of rGt, I256V obviously reduced the virulence of virulent IBDV. The present results demonstrate for the first time, to different extent, residues 249 and 256 of VP2 are involved in the replication efficiency and virulence of IBDV; this is not only beneficial to further understanding of pathogenic mechanism but also to the design of newly tailored vaccines against IBDV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Birnaviridae Infections / veterinary*
  • Birnaviridae Infections / virology*
  • Capsid Proteins / chemistry
  • Capsid Proteins / genetics*
  • Chickens / virology
  • Infectious bursal disease virus / chemistry
  • Infectious bursal disease virus / genetics*
  • Infectious bursal disease virus / pathogenicity*
  • Models, Molecular
  • Mutagenesis, Site-Directed
  • Mutation
  • Protein Structure, Tertiary
  • Virus Replication

Substances

  • Capsid Proteins

Grants and funding

This study was supported by grants from the National Natural Science Foundation of China (number 30901083), the National Basic Research Program (973) of China (number 2005CB523202), and the China-France Cai-Yuanpei Program (2011008007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.